Antibiotic class | Antibiotic | 19B23009 (Patient 1) | 19W05620 (Patient 3) | 19W06265 (Patient 4) | |||||
---|---|---|---|---|---|---|---|---|---|
MIC / Inhibition diameter (µg/mL/mm) | Interpretation | MIC / Inhibition diameter (µg/mL/mm) | Interpretation | MIC / Inhibition diameter (µg/mL/mm) | Interpretation | ||||
β-Lactams | Piperacillin/Tazobactam | ≥ 128 | Resistant | ≥ 128 | Resistant | ≥ 128 | Resistant | ||
Ceftriaxone | 8 | Resistant | ≥ 64 | Resistant | 8 | Resistant | |||
Ceftazidime | 2 | Susceptible | ≥ 64 | Resistant | 2 | Susceptible | |||
Cefepime | ≤ 0.12 | Susceptible | 4 | Intermediate | ≤ 0.12 | Susceptible | |||
Cefoperazone/Sulbactam | 16 | No criteria | ≥ 64 | No criteria | 16 | No criteria | |||
Cefuroxime | ≥ 64 | Resistant | ≥ 64 | Resistant | ≥ 64 | Resistant | |||
Cefoxitin | ≥ 64 | Resistant | ≥ 64 | Resistant | ≥ 64 | Resistant | |||
Imipenem | 8 | Resistant | 8 | Resistant | 8 | Resistant | |||
Meropenem | 31 | Susceptible | 13 | Resistant | 26 | Susceptible | |||
Amoxycillin/clavulanic acid | 4 | No criteria | ≥ 32 | No criteria | 4 | No criteria | |||
Aminoglycoside | Amikacin | ≤ 2 | Susceptible | ≤ 2 | Susceptible | ≤ 2 | Susceptible | ||
Trimethoprim-sulfonamide | Trimethoprim-Sulfonamide | 8 | No criteria | ≥ 16 | No criteria | 8 | No criteria | ||
Fluoroquinolone | Levofloxacin | 0.5 | Susceptible | 2 | Susceptible | 0.5 | Susceptible | ||
Glycylcycline | Tigecycline | ≤ 0.05 | No criteria | ≤ 0.05 | No criteria | ≤ 0.05 | No criteria |